BRENDA MINTZ: Open Payments
NPI 1306170402 · BRONX, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$684 in 38 payments from 8 companies in 2025. Trend: 2023 $792 · 2024 $1,040 · 2025 $684
Food & beverage: $684
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $239 |
| Galderma Laboratories, L.P. | 9 | $154 |
| Novartis Pharmaceuticals Corporation | 6 | $125 |
| Lilly USA, LLC | 3 | $59 |
| Arcutis Biotherapeutics, Inc. | 1 | $31 |
| E.R. Squibb & Sons, L.L.C. | 2 | $30 |
| Incyte Corporation | 1 | $26 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $20 |
Products named: SKYRIZI, COSENTYX, NEMLUVIO, RINVOQ, TALTZ, Zoryve, Sotyktu, OPZELURA.
Industry payments across NY — which companies pay providers there.
